Does CARVEDILOL Cause Neoplasm malignant? 23 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Neoplasm malignant have been filed in association with CARVEDILOL (Carvedilol Phosphate). This represents 0.2% of all adverse event reports for CARVEDILOL.
23
Reports of Neoplasm malignant with CARVEDILOL
0.2%
of all CARVEDILOL reports
5
Deaths
11
Hospitalizations
How Dangerous Is Neoplasm malignant From CARVEDILOL?
Of the 23 reports, 5 (21.7%) resulted in death, 11 (47.8%) required hospitalization, and 1 (4.3%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARVEDILOL. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does CARVEDILOL Cause?
Hypotension (1,822)
Dyspnoea (1,143)
Dizziness (1,138)
Drug ineffective (1,102)
Fatigue (1,020)
Completed suicide (1,019)
Bradycardia (861)
Toxicity to various agents (690)
Cardiac failure (636)
Asthenia (562)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which CARVEDILOL Alternatives Have Lower Neoplasm malignant Risk?
CARVEDILOL vs CASIMERSEN
CARVEDILOL vs CASIRIVIMAB
CARVEDILOL vs CASIRIVIMAB\IMDEVIMAB
CARVEDILOL vs CASPOFUNGIN
CARVEDILOL vs CATEQUENTINIB